Welcome to our dedicated page for Xos SEC filings (Ticker: XOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Xos, Inc. (NASDAQ: XOS) SEC filings page on Stock Titan brings together the company’s official regulatory disclosures, including annual and quarterly reports, current reports on Form 8-K, and other key documents filed with the U.S. Securities and Exchange Commission. Xos is an electric truck manufacturer, technology company, and fleet services provider for battery-electric commercial fleets, and its filings provide detailed insight into this business.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, Xos presents audited and interim financial statements, management’s discussion and analysis, and information about its medium-duty electric vehicles, mobile charging and energy storage products, fleet services, and risk factors. These reports help investors understand revenue from vehicle and equipment sales, gross margin trends, operating expenses, cash flows, and capital structure over time.
Current reports on Form 8-K give more immediate updates on specific events. Recent 8-K filings have covered quarterly earnings releases, amendments to a convertible promissory note, establishment of an at-the-market equity offering program, changes to manufacturing facility leases, executive employment agreements, board appointments, and shareholder votes on equity incentive plan amendments. These documents outline material developments affecting Xos’s operations, governance, and financing.
On this page, users can also access filings related to equity and debt transactions, such as note purchase agreements and sales agreements for common stock, as well as exhibits that describe key contracts. Together, these filings provide a comprehensive view of how Xos manages its growth in electric commercial vehicles and mobile charging solutions, its governance practices, and its approach to capital raising.
Stock Titan enhances access to XOS filings with AI-powered summaries that explain the main points of lengthy documents, highlight important changes, and make it easier to locate information about topics such as quarterly performance, lease commitments, equity plans, and material agreements.
Emerald Green Trust, reporting as a director and 10% owner of Xos, Inc. (XOS), disclosed routine insider sales executed under a Rule 10b5-1 trading plan adopted May 27, 2025. The Form 4 reports three non-derivative sales of common stock: on 09/04/2025 the trust sold 13,110 shares at a weighted-average price of $2.2758 leaving 1,624,087 shares; on 09/05/2025 it sold 5,479 shares at $2.3042 leaving 1,618,608 shares; and on 09/08/2025 it sold 11,686 shares at $2.2871 leaving 1,606,922 shares. The filing is signed by Sarah Bardo as trustee on 09/08/2025. The filing notes the reported prices are weighted averages and that detailed per-price quantities are available upon request.
Emerald Green Trust, acting as a director-related reporting person for Xos, Inc. (XOS), reported three scheduled sales of common stock executed under a Rule 10b5-1 trading plan adopted May 27, 2025. The sales occurred on 08/29/2025 (19,731 shares at a weighted average price of $2.8889), 09/02/2025 (24,593 shares at $2.6191) and 09/03/2025 (19,333 shares at $2.4764). Following these dispositions the reporting person beneficially owned 1,637,197 shares. The filings state the price ranges for each sale date and note that full per-price breakdowns are available upon request.
Emerald Green Trust, a reporting person identified as a director and 10% owner of Xos, Inc. (XOS), sold a total of 90,676 shares of XOS common stock across three transactions on 08/26/2025 (41,894 shares), 08/27/2025 (28,384 shares) and 08/28/2025 (20,398 shares). The disposals were effected under a previously established Rule 10b5-1 trading plan adopted May 27, 2025. Weighted average sale prices are reported for each date (approximately $3.02 to $3.04), and the reporting person states full price-by-price detail will be provided on request. After these sales, Emerald Green Trust beneficially owned 1,700,854 shares of XOS common stock.
Xos, Inc. disclosed two material items in an 8-K. First, on August 21, 2025 the company entered a Lease Termination Agreement for its 235,094 sq ft Mesa, Arizona manufacturing facility leased by subsidiary EMV Automotive USA Inc. The termination is contingent on the landlord securing a replacement tenant; if no replacement is found the lease remains in effect through its 2033 expiration.
Under the agreement Xos will pay approximately $2.7 million in monthly payments over 18 months after termination, forfeit a security deposit of ~$1.2 million, and pay leasing commissions of ~$1.3 million. Xos said it will continue using other manufacturing sites and does not anticipate operational impact. Second, as disclosed, on August 25, 2025 the company issued 1,803,262 shares to Aljomaih Automotive Company to satisfy ~$6.0 million of accrued interest on a convertible note, converted at the 10-day VWAP.
Xos, Inc. (XOS) filed a Form 144 notifying intent to sell 200,000 shares of Common Stock through Piper Sandler & Co. The filing lists an aggregate market value of $616,000 and reports 8,690,583 shares outstanding. The shares were acquired on 08/20/2021 as SPAC merger shares and the proposed approximate sale date is 08/26/2025. The filer reports no securities sold in the past three months and provides the standard representation that the seller is not aware of any undisclosed material adverse information. The filing does not include details on the seller's identity, reason for sale, or any trading plan dates.
John F. Smith, identified as a director of Xos, Inc. (XOS), filed an initial Form 3 reporting no beneficial ownership of the issuer's common stock. The event date is 08/18/2025 and the form was signed by an attorney-in-fact on 08/22/2025. The filing indicates 0 shares beneficially owned and shows the Form 3 was submitted by a single reporting person.
Xos, Inc. expanded its board from eight to nine directors and elected John F. Smith as a Class I director effective August 18, 2025, with a term running until the 2028 annual meeting or until his successor is elected. The Board simultaneously appointed Mr. Smith to the Audit Committee. Mr. Smith is Principal of Eagle Advisors LLC since 2011 and previously served in senior roles including Group Vice President at General Motors after a 42-year tenure; he also held board positions at several public companies through 2025. He will receive standard non-employee director compensation described in the Company’s Definitive Proxy Statement and entered into the Company’s customary indemnification agreement dated August 18, 2025. The Company furnished a press release on August 22, 2025 announcing the appointment.
Stuart N. Bernstein, a director of Xos, Inc. (XOS), reported the sale of 14,347 shares of common stock on 08/18/2025 under a previously established Rule 10b5-1 trading plan. The filing shows a weighted average sale price of $3.07, with actual sale prices ranging from $3.05 to $3.10. After the sale, the reporting person beneficially owned 98,158 shares, which includes 62,377 unvested restricted stock units. An additional 4,133 shares are held indirectly by Bernstein Investment Partners LLC, where the reporting person is Managing Member. The Form 4 was signed by an attorney-in-fact on 08/20/2025.
XOS (Xos, Inc.) Form 144 notice shows a proposed sale of 28,694 shares of common stock through UBS Financial Services with an aggregate market value of $86,082, scheduled approximately for 08/18/2025 on NASDAQ. The shares were acquired by the seller via RSA vesting on 06/23/2025 and payment/issuance occurred the same day. The filing lists past open-market disposals by the same person on 05/27/2025 (1,305 shares) and 05/28/2025 (3,468 shares) with stated gross proceeds. The notice includes the seller's standard representation that they have no undisclosed material adverse information about the issuer.
Form 144 notice for XOS, Inc. (XOS) discloses a proposed sale of 14,347 shares of common stock through UBS Financial Services on the NASDAQ, with an aggregate market value of $43,041. The filing lists 8,029,000 shares outstanding and an approximate sale date of 08/18/2025.
The shares to be sold were acquired by the holder through restricted stock unit vesting: 4,591 shares vested on 05/30/2023 and 9,756 shares vested on 06/12/2024. The filer reports no securities sold in the past three months and affirms they are not aware of undisclosed material adverse information about the issuer.